---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-049630"
form_type: "8-K"
ticker: "TELO"
cik: "0001971532"
company_name: "Telomir Pharmaceuticals, Inc."
filed_at: "2024-12-11T23:59:59+00:00"
generated_at: "2026-05-29T04:50:20.435758+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Telomir Pharmaceuticals raises $1M at $7/share (20% premium) in no-warrant private placement

## Summary
- Issued 142,857 shares at $7/share to an accredited investor, a 20% premium to Dec 9 closing price.
- Total proceeds $1M; no warrants issued, minimizing dilution.
- Same investor extended a $5M non-dilutive line of credit earlier in 2024, currently undrawn.
- Exempt from registration under Section 4(a)(2) of the Securities Act.

## SEC filing metadata
- accession: 0001493152-24-049630
- form_type: 8-K
- ticker: TELO
- cik: 0001971532
- company_name: Telomir Pharmaceuticals, Inc.
- filed_at: 2024-12-11T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 3.02, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1971532/000149315224049630/0001493152-24-049630-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1971532/000149315224049630/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-049630
- JSON: https://secwatch.observer/filing/0001493152-24-049630.json
- Plain text: https://secwatch.observer/filing/0001493152-24-049630.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.